CIK 0001674335
- Accelerated filer
JELD-WEN Holding, Inc.
Sign in to watch- Ticker
- JELD
- Exchange
- NYSE
- Industry
- Millwood, Veneer, Plywood, & Structural Wood Members
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 931273278
- Phone
- +1 704-378-5700
- Business address
- 2645 SILVER CRESCENT DRIVE, CHARLOTTE, NC, 28273
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,850
- in 1 filing
Net −$347,850. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-09 | Farmakis Peter EVP & President, Australasia | Exercise or conversion | +3,520 | $18.79 | $66K | 246,786 |
| 2021-08-09 | Farmakis Peter EVP & President, Australasia | Exercise or conversion | +9,911 | $20.96 | $208K | 256,697 |
| 2021-08-09 | Farmakis Peter EVP & President, Australasia | Sale | −13,431 | $27.84 | $374K | 158,886 |
| 2021-08-09 | Farmakis Peter EVP & President, Australasia | Sale | −25,050 | $27.86 | $698K | 133,836 |
| 2021-08-09 | Farmakis Peter EVP & President, Australasia | Exercise or conversion · Common Stock Option (Right to Buy) | −3,520 | 0 | ||
| 2021-08-09 | Farmakis Peter EVP & President, Australasia | Exercise or conversion · Common Stock Option (Right to Buy) | −9,911 | 0 | ||
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Exercise or conversion | +52,240 | $6.74 | $352K | 216,126 |
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Exercise or conversion | +10,560 | $9.97 | $105K | 226,686 |
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Exercise or conversion | +13,060 | $10.76 | $141K | 239,746 |
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Exercise or conversion | +3,520 | $14.07 | $50K | 243,266 |
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Sale | −62,800 | $28.00 | $1.8M | 193,897 |
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Sale | −5,000 | $28.13 | $141K | 188,897 |
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Sale | −16,580 | $28.09 | $466K | 172,317 |
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Exercise or conversion · Common Stock Option (Right to Buy) | −52,240 | 0 | ||
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Exercise or conversion · Common Stock Option (Right to Buy) | −10,560 | 0 | ||
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Exercise or conversion · Common Stock Option (Right to Buy) | −13,060 | 0 | ||
| 2021-08-06 | Farmakis Peter EVP & President, Australasia | Exercise or conversion · Common Stock Option (Right to Buy) | −3,520 | 0 | ||
| 2021-06-01 | Farmakis Peter EVP & President, Australasia | Sale | −5,336 | $28.51 | $152K | 163,886 |
| 2021-02-23 | Farmakis Peter EVP & President, Australasia | Grant or award | +8,861 | 169,222 | ||
| 2021-02-23 | Farmakis Peter EVP & President, Australasia | Grant or award · Common Stock Option (Right to Buy) | +17,865 | 17,865 |
Page 1 of 2 · 30 trades